Oberweis Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Oberweis Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-88,600	Closed	-$372K	–	188
2020 Q4	$372K	Sell	88,600 -84,250	-49%	-$325K	0.1%	104
2020 Q3	$645K	Sell	172,850 -158,850	-48%	-$676K	0.22%	75
2020 Q2	$1.45M	Buy	331,700 +197,800	+148%	+$889K	0.57%	32
2020 Q1	$507K	Sell	133,900 -22,200	-14%	-$109K	0.28%	84
2019 Q4	$987K	Buy	+156,100	New	+$918K	0.33%	77

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oberweis Asset Management's BDSI Position: Q1 2021 in Review

Oberweis Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2021, closing a stake of 88,600 shares — an estimated $372K sold.

Oberweis Asset Management first reported a position in BDSI in Q4 2019 and held it in 5 quarters. The position peaked at $1.45M in Q2 2020. 151 funds tracked by Wall St. Rank hold BDSI as of Q1 2021.

Oberweis Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2021 after selling out during the quarter.
Oberweis Asset Management sold 88,600 BioDelivery Sciences International, Inc. shares in Q1 2021, an estimated $372K.
Oberweis Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 5 quarters.
Oberweis Asset Management's BioDelivery Sciences International, Inc. position peaked at $1.45M in Q2 2020.
151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2021.

Based on Oberweis Asset Management's 13F filing for Q1 2021, filed 17 May 2021.